Key facts
- It has raised $77.6M across 3 recorded rounds; the latest was Seed Round ($606K) in Oct 2019.
- Notable investors include National Development and Reform Commission.
- Synata Bio has filed 6 Form Ds with the SEC since 2015, most recently Feb 2021 ($606K sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Synata Bio
Funding rounds
3 roundsAbout Synata Bio
Developer of a fermentation technology designed to process synthesis gas from multiple sources into products. The company's technology is a non-GMO biocatalyst that harmonizes all feedstocks with carbon utilization and an efficient gas-to-liquids platform, enabling chemical companies to access a sustainable technology to produce primary alcohols.
- Sector
- Materials and Resources
- HQ
- Warrenville, IL, United States
- Founded
- 2015
- Employees
- 38
- Website
- synatabio.com/
- Ownership
- Privately Held (backing)
Synata Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synata Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synata Bio in its N-PORT filings yet. We sweep new filings monthly.